false
OasisLMS
Catalog
Utilizing Next-Generation Digital Health Technolog ...
Presentation and Q&A
Presentation and Q&A
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
In the first video, Dr. John Torres discusses the use of digital health technology to improve care for people with serious mental illness (SMI). The video is part of the SMI Advisor webinar, with Dr. Timothy Angst as the speaker. Dr. Angst explains the different categories of digital health technology and highlights the importance of digital biomarkers in monitoring and intervening in patient care. He discusses the potential impact of digital health on telehealth, medication optimization, wearable devices, and self-care management. Dr. Angst also discusses the potential of digital therapeutics and prescribed digital therapies.<br /><br />In the second video, Dr. Michael Oberlander explores the potential of digital health interventions for improving patient care in mental health. He emphasizes the importance of data collection and analysis in tailoring treatment options and mentions the use of wearable devices to passively monitor patients' behaviors. Dr. Oberlander discusses the potential of digital biomarkers and provides examples of FDA-cleared digital therapies. He discusses the need for evidence and validation of these interventions and addresses privacy and legal implications. Dr. Oberlander concludes by urging healthcare providers to assess their patient populations, resources, and desired outcomes before adopting digital health interventions and emphasizes the importance of understanding workflow, data privacy, and patient engagement.<br /><br />Both videos provide valuable insights into the current and potential applications of digital health technology in improving care for people with serious mental illness and mental health conditions.
Keywords
digital health technology
serious mental illness
digital biomarkers
telehealth
wearable devices
self-care management
digital therapeutics
data collection and analysis
FDA-cleared digital therapies
patient engagement
×
Please select your language
1
English